A freelance journalist faults the “fundamentally corrupt and unjust system” that allows big pharma and others to hoard scientific knowledge instead of using it for the greatest public good.
Zaitchik offers a biting study of the “double protection racket” through which drug companies benefit from government-subsidized research and then use patents to reap unseemly profits from it. Beginning with the Renaissance princes whose “royal grants” amounted to proto-patents, the author gives a dense but clear history of how scientific patents have promoted “monopoly medicine.” Zaitchik argues that patents were envisioned by the framers of the Constitution as a two-way social contract for advancing science and “useful arts” but have become a vehicle for turning vital medical knowledge into private intellectual property. That process sped up with the passage of the Bayh-Dole Act in 1980, which allowed businesses and universities to retain the rights to knowledge developed with federal funding, and it helped to make possible the “vaccine nationalism” of Operation Warp Speed. Drawing on deep research, Zaitchik knocks the halos off three prominent players in the pandemic: Pfizer (whose CEO fought generic drugs in the 1980s); Moderna (two of whose executives dumped $30 million in stock in a legal but suspiciously timed move after the company announced promising vaccine trial results); and Bill Gates, the focus of a chapter called “Pharma’s Best Friend: Bill Gates and Covid-19.” The author makes a strong case that Gates tried to undermine the efforts of experts who predicted a global vaccine supply crisis with his insistence that market forces could ensure a fair distribution of vaccines among rich and poor nations, a view that has proved “catastrophically incorrect” given that half the world’s population remains unvaccinated against Covid. While big pharma often gets the sole blame for soaring drug prices, this book is a brave and timely reminder that politicians and corporate titans have enabled its excesses.
A trenchant study of the dangers of turning medical knowledge into private intellectual property.